Skip to main content
STS 2024 Annual Meeting Main banner

Adult Cardiac

Late-Breaking

Late Breaker: SAVR vs. TAVR in Low Risk Patients...What's the Data So Far?

Monday, January 29, 2024
7:15 AM - 8:45 AM CT
Location: 304ABC

    Moderator(s)

  • Thomas MacGillivray, MD

    Physician Executive Director and Chair, Cardiac Surgery
    MedStar Washington Hospital Center
    Washington, District of Columbia, United States

    Disclosure(s): No financial relationships to disclose

  • Elaine Tseng, MD (she/her/hers)

    Professor of Surgery
    University of California San Francisco and San Francisco VA Medical Centers
    University of California San Francisco
    South San Francisco, California, United States

    Disclosure(s): Amgen Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion,: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Avania/Cellphire: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Portrero Med Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 28, 2022)

Disclosure(s):
Thomas E. MacGillivray, MD: No financial relationships to disclose
Elaine Tseng, MD: Amgen Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion,: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Avania/Cellphire: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Portrero Med Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 28, 2022)

Presentations:

  • 7:15 AM - 7:25 AM CT
    Five Year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-Risk Randomized Trial

    Invited Speaker: Michael Mack, MD – Baylor Scott & White Health

  • 7:25 AM - 7:35 AM CT
    Four Year Outcomes from the EVOLUT Low Risk Trial

    Invited Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center

  • 7:35 AM - 7:45 AM CT
    Survival after SAVR in Low-Risk Patients: A Contemporary Trial Benchmark

    Invited Speaker: Vinay Badhwar, MD – West Virginia University

  • 7:45 AM - 7:55 AM CT
    Late Breaking: Five Year Clinical and Echocardiographic Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 Trial

    Presenting Author: Vinod H. Thourani, MD – Piedmont Heart Institute and Piedmont Healthcare

  • 7:55 AM - 8:45 AM CT
    Panel Discussion and Audience Q&A

    Panelist: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center

    Panelist: Michael Mack, MD – Baylor Scott & White Health

    Panelist: Vinay Badhwar, MD – West Virginia University

    Panelist: Vinod H. Thourani, MD – Piedmont Heart Institute and Piedmont Healthcare